Why Does Plasma Form Such Robust Fibrin Clots – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by François Caton et al, adding:
“Why does plasma form such robust fibrin clots?
Fibrin clot architecture is a recognised signature of cardiovascular disease, but the fundamental mechanisms linking clot-forming chemistry to clot structure in plasma remain poorly understood. A new study in RPTH Journal takes a rigorous quantitative approach to answer this question.
Key findings comparing plasma clots with purified fibrinogen/thrombin systems:
In purified systems, a 100-fold increase in thrombin concentration caused a 30-fold decrease in protofibril number and a 5-fold change in pore size, highly sensitive to trigger concentration
In contrast, plasma clots showed remarkable robustness: a 40-fold increase in tissue factor concentration resulted in only a 2-fold change in protofibril number, with minimal pore size evolution
Purified and plasma clots appeared morphologically identical, their ultrastructural parameters behaved fundamentally differently
Key driver: it is the characteristic shape of the thrombin burst over time, not the total amount of thrombin produced, that governs plasma fibrin architecture
This inherent robustness of plasma clot formation may explain the existence of a ‘normal’ clot structure, and positions fibrinography as a promising structural biomarker for detecting deviations from this norm in cardiovascular disease.”
Title: Thrombin kinetics determines robust plasma clot architecture
Authors: François Caton, Landry Seyve, Carhel Dassi, Denis Roux, Benoît Polack
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience